We report an optimized synthesis of all canonical 2 0 -O-TOM protected ribonucleoside phosphoramidites and solid supports containing [ 13 C 5 ]-labeled ribose moieties, their sequence-specific introduction into very short RNA sequences and their use for the structure determination of two protein-RNA complexes. These specifically labeled sequences facilitate RNA resonance assignments and are essential to assign a high number of sugar-sugar and intermolecular NOEs, which ultimately improve the precision and accuracy of the resulting structures. This labeling strategy is particularly useful for the study of protein-RNA complexes with singlestranded RNA in solution, which is rapidly an increasingly relevant research area in biology.
INTRODUCTION
Unambiguous RNA resonance assignments and identification of a sufficient number of intermolecular NOEs is often one of the limiting factors preventing a rapid structure determination of protein-RNA complexes with NMR spectroscopy (1, 2) . Reasons for this limitation originate from the severe resonance overlap that is present in RNA compared to proteins especially within the sugar protons of the RNA that all resonate within one p.p.m. except for the anomeric proton (3) . To overcome this problem, methods based on in vitro transcription have been developed to isotopically label RNA with 13 C and 15 N and to facilitate RNA resonance assignments and the structure determination of RNAs and protein-RNA complexes (4, 5) . Although, they have been successfully used to study RNA of 20 nt or more in size in complex with proteins (1, 2) , labeling methods to produce short RNA oligonucleotides (2 to 10 in size) by in vitro transcription failed (6) . Yet, isotopic labeling of short RNAs would be very useful to confidently assign the resonances of short RNAs in complex with proteins and to improve the precision of the resulting structures. Recently, three structures of proteins in complex with short single-stranded RNAs have been determined with NMR spectroscopy, namely SF1 (7) , TIS 11d (6) and the Argonaute PAZ domain (8) . All three were studied with unlabeled RNA making the resonance assignment of the RNA in complex very challenging, especially in the presence of an RNA with low sequence complexity like 5 0 -UUAUUUAUU-3 0 used in the TIS 11d -RNA complex (6) .
Here, we report the synthesis of several short RNA sequences (4 to 7 nt) with [ 13 C 5 ]-labeled riboses at specific positions and their application for the resonance assignments and for the structure determination of two alternative-splicing factors, polypyrimidine tract binding protein (PTB) and feminizing locus on X (Fox-1), in complex with RNA. For this purpose, we evaluated and optimized the various reported synthetic methods (9) (10) (11) (12) for the preparation of [ 13 C 5 ]ribonucleosides from [ 13 C 6 ]-D-glucose. These intermediates were then converted into the corresponding 2 0 -O-[(triisopropylsilyl)oxy]methyl (¼ 2 0 -O-TOM) protected ribonucleoside phosphoramidites, which allows an efficient preparation of RNA sequences under DNA coupling conditions (13, 14) . Chemical synthesis allows efficient 13 C-labeling of very short RNAs and the possibility to introduce isotope-labeling at any position in the sequence, providing a fundamental advantage over isotope-labeling by in vitro transcription (1, 2) . Using chemically synthesized 13 C-labeled RNA, RNA resonance assignment was greatly facilitated as several ambiguities could be resolved. Also a very high number of intermolecular and intramolecular sugar-sugar NOE cross-peaks could be assigned permitting to obtain structures of very high precision (15, 16) .
MATERIALS AND METHODS

General
Reagents and solvents (highest purity) from various suppliers, used without further purification, unless otherwise stated. [1, 2, 3, 4, 5, [6] [7] [8] [9] [10] [11] [12] [13] 
Prepared essentially according to Saito et al. (17) , for experimental details see Supplementary Data.
A suspension of 1 (3.20 g, 7.15 mmol) and 2-amino-6-chloro-N 2 -isobutyrylpurine (2.06 g, 8.61 mmol) in (CH 2 Cl) 2 (28 ml) was treated with N,O-bis(trimethylsilyl)acetamide (2.63 ml, 10.77 mmol). After 15 min at 65 C, TMS-OTf (4.53 ml, 25.13 mmol) was added and the mixture was stirred 30 min at 65 C. After usual work up, the intermediate 2 was dissolved in allyl alcohol (23 ml), treated with DABCO (1.21 g, 10.77 mmol) and DBU (1.61 ml, 10.77 mmol). After 1 h at 20 , the reaction mixture was diluted with CH 2 Cl 2 (150 ml), extracted with 10% citric acid (200 ml), washed with saturated NaHCO 3 (150 ml) and dried over MgSO 4 . After evaporation, the residue was dissolved in THF/MeOH 5:4 (180 ml), cooled to 0 and treated with 2N NaOH (18 ml). After 10 min at 0 , ion exchange resin IR 120 (H + form, 30 ml) was added until the pH 7. The resin was filtered off and washed with THF/MeOH 5:4. The solvents were evaporated; the residue was co-evaporated with pyridine and dried under vacuum (0.01 mbar). The residue was dissolved in pyridine (30 ml) and treated with (MeO) 2 
A solution of 3 (3.44 g, 4.91 mmol) in CH 2 Cl 2 (20 ml) was treated with Et 2 NH (1.28 ml, 12.3 mmol), PPh 3 (296 mg, 1.13 mmol) and Pd(PPh 3 ) 4 (30 mg, 0.03 mmol). After 30 min at 20 , SiO 2 (9 g) was added and the solvent was evaporated. [1 0 ,2 0 ,3 0 ,4 0 ,5 0 -13 C 5 ]-N 6 -Benzoyl-5 0 -O-(4,4 0dimethoxytrityl)adenosine (5) A suspension of 1 (3.20 g, 7.15 mmol) and N 6 -benzoyladenine (2.05 g, 8.59 mmol) in (CH 2 Cl) 2 (28 ml) was treated with N,O-bis(trimethylsilyl)acetamide (2.62 ml, 10.74 mmol). The mixture was stirred at 65 C for 15 min, treated with SnCl 4 (2.9 ml, 25.06 mmol) and stirred 30 min at 65 C. After usual work up, the residue was dissolved in THF-MeOH 5:4 (250 ml), cooled to 0 and treated with 2N NaOH (25 ml). After 40 min at 0 , ion exchange resin IR 120 (H + form, 30 ml) was added until the pH 7. The resin was filtered off and washed with THF-MeOH 5:4. The solvents were evaporated; the residue was co-evaporated with pyridine and dried under vacuum (0.01 mbar). The residue was dissolved in pyridine (30 ml) and treated with (MeO) 2 TrCl (3.20 g, 9.5 mmol). After 1 h at 20 , the reaction mixture was subjected to usual work up. CC [75 g SiO 2 , CH 2 Cl 2 (+2% NEt 3 ) ! CH 2 Cl 2 /MeOH 24:1 (+2% NEt 3 )] gave 5 
A suspension of 1 (1.70 g, 3.80 mmol) and uracil (0.52 g, 4.64 mmol) in MeCN (19 ml) was treated with N,O-bis(trimethylsilyl)acetamide (2.80 ml, 11.1 mmol) and stirred at 60 C for 30 min. Then, TMS-OTf (2.44 ml, 13.3 mmol) was added and the mixture was stirred 30 min at 60 C. After usual work up, the resulting intermediate was dissolved in 8 M MeNH 2 in EtOH (19 ml) and stirred overnight at 20 . The solvent was evaporated; the residue was co-evaporated with pyridine and dried overnight under vacuum (0.01 mbar). The solid was dissolved in pyridine (19 ml) and treated with (MeO) 2 TrCl (1.80 g, 5.32 mmol). After 1 h at 20 , the reaction mixture was subjected to usual work up. CC (40 g SiO 2 , CH 2 Cl 2 (+2% Et 3 N) ! CH 2 Cl 2 /MeOH 19:1 (+2% Et 3 N)) gave 7 (1.49 g, 71%) as pink foam. TLC (CH 2 Cl 2 /MeOH 9:1) R f 0.50. 1 
Prepared essentially according to Pitsch et al. (14) , for experimental details see Supplementary Data. 
Prepared according to Pitsch et al. (14) , for experimental details see Supplementary Data.
Solid supports
Prepared according to Pitsch et al. (14) , for structures and experimental details see Supplementary Data.
Assembly and deprotection of RNA sequences S1-S6
The RNA sequences S1-S6 were assembled from the 13 C 5labeled phosphoramidites 11-14 and the corrresponding 2 0 -O-TOM protected, unlabeled phosphoramidites on a Gene Assembler Plus (Pharmacia) in a 1 mmol scale according to (14) . After the assembly, the solid supports were treated with a 1:1 mixture of 12 M MeNH 2 in H 2 O/8 M MeNH 2 in EtOH (1 ml) for 3 h at 35 . By centrifugation, the supernatant solution was separated from the solid support and evaporated, and the residue was dissolved in 1 M Bu 4 NF·3 H 2 O solution in THF (1 ml). After 14 h at 20 , 1 M Tris-HCl buffer (pH 7.4, 1 ml) was added and the solution concentrated to half its volume.
Desalting and purification of RNA sequences r(
The remaining solution from above (1 ml) was applied on a NAP-10 cartridge (Pharmacia) and eluted with H 2 O. Two fractions were collected: fraction 1 (1.5 ml) and fraction 2 (1 ml). Fraction 2 was again applied to a NAP-10 cartridge and eluted with H 2 O. The first 1.5 ml solution was combined with fraction 1 and purified by anion exchange-highperformance liquid chromatography (HPLC): Pharmacia Source 15Q column (4.5 · 100 mm), flow 2 ml/min, eluent A: 50 mM NEt 3 ·H 2 CO 3 , eluent B: 1 M NEt 3 ·H 2 CO 3 , detection at 260 nm, elution at 20 , gradient 0-45% B in 40 min, 1 injection. The fractions containing pure product were pooled and subjected to lyophilization. In order to completely remove the remaining NEt 3 ·H 2 CO 3 , 0.5 ml H 2 O were added to the residue, followed by lyophilization (this procedure was carried out twice). The residue was dissolved in H 2 O (0.5 ml), treated with NaHCO 3 (5 mg) and lyophilized twice. Final desalting on a NAP-10 cartridge was performed as described above, resulting in pure RNA sequences S1-S4 as Na + salts.
Their amount was determined spectrophotometrically. S1 The cartridge was washed with 20 mM Et 3 N·H 2 CO 3 (10 ml) and the RNA sequences were eluted with MeCN/H 2 O 1:1 (4 ml). In order to completely remove the remaining NEt 3 ·H 2 CO 3 , 0.5 ml H 2 O were added to the residue, followed by lyophilization (this procedure was carried out twice). The residue was dissolved in H 2 O (0.5 ml), treated with NaHCO 3 (10 mg) and lyophilized twice. Final desalting on a NAP-10 cartridge was performed as described above, resulting in pure RNA sequences S5 and S6 as Na + salts. Their amount was determined spectrophotometrically. distance constraints from the unlabeled RNA sequence was performed in a restrained simulated annealing run using AMBER 7.0, following the same protocol that was employed for the structure calculation of the Fox-1 complex with the entire set of constraints; see (15) .
RESULTS AND DISCUSSION
Preparation of the 13 C 5 -ribose-labeled ribonucleoside phosphoramidites
For the preparation of the four canonical, 13 C 5 -ribose-labeled 2 0 -O-TOM protected ribonucleoside phosphoramidites and solid supports, we adapted and optimized existing reaction conditions with the purpose of minimizing the number of time-consuming purification steps (Scheme 1). The fourstep synthesis of the protected 13 C 5 -ribose derivative 1 from 13 C 6 -labeled D-glucose (40% yield) was carried out essentially according to Saito et al. (17) and is described in the Supplementary Data. The protected adenosine and uridine derivatives 5 and 6 were obtained by nucleosidation of 1 with N 6 -benzoyladenosine (! 5) and uracil (! 6), respectively, under optimized Vorbru¨ggen conditions, followed by partial deacylation and dimethoxytritylation. The guanosine derivative 6 was prepared according to a modified method originally described for the synthesis of the corresponding ribopyranosylguanosine phosphoramidite by Pitsch et al. 4 ], resulting in formation of the guanosine derivative 4 (89% yield). The introduction of the 2 0 -O-TOM protecting group into nucleosides 4, 5 and 6 was carried out according to our standard procedure (14) , with Bu 2 SnCl 2 , i Pr 2 NEt and TOM-Cl in 1,2-dichloroethane at 80 (detailed procedure in Supplementary Data). The product mixture was separated into the 2 0 -O-TOM protected products 7-9, the unreacted starting materials, and the 3 0 -O-TOM protected regioisomers. The latter were deprotected with Et 4 NF in MeCN, the products were combined with the unreacted starting materials and subjected again to alkylation with TOM-Cl. By this procedure, the 2 0 -O-TOM protected nucleosides 7-9 were obtained in fair yields of 42-50% (Scheme 1). From the 2 0 -O-TOM protected uridine 9, the corresponding cytidine derivative 10 was obtained according to our published method (18) , in a yield of 65%. Under standard conditions, the four 2 0 -O-TOM protected nucleosides 7-10 were converted with 2-cyanoethyl diisopropylphosphoramidochloridite/ i Pr 2 NEt in CH 2 Cl 2 into their corresponding phosphoramidite building blocks (Scheme 1). The solids supports were prepared according to (14) by first synthesizing the 2 0 -O-(nitrophenylheptane)dioates from the 3 0 -O-tom nucleosides of adenosine, uridine and cytosine and the 3 0 -O-(nitrophenylheptane)dioate from the 2 0 -O-TOM guanosine derivative. Then these activated esters were immobilized on 500 s (aminoalkyl)-functionalized controlled pore glass (CPG) with loadings from 25 to 35 mmol/g (a detailed description for the preparation of phosphoramidites 7-14 and the corresponding solid supports is given in the Supplementary Data) .
Chemical synthesis of the short 13 C-labeled RNA oligonucleotides
The short and partially labeled RNA sequences S1-S6 (Table 1) were assembled in 1 mM batches from conventional 2 0 -O-TOM protected ribonucleoside phosphoramidites and solid supports, and the corresponding 13 C-labeled building blocks 11-14, respectively, on an oligonucleotide synthesizer according to our standard protocols (14) . The isolation and purification protocols of the shortest 4 and 5mer oligonucleotides S1-S4 had to be modified, because of the small size and small number of negative charges present (for a detailed procedure see Materials and Methods). Finally, all RNA sequences were converted into their Na + salts and characterized by MALDI-MS (Table 1) .
NMR study of the 13 C 5 -sugar labeled UCUCU and CUCU in complex with PTB The oligo(CU) sequences S1-S4 ( Supplementary Table) containing 13 C 5 -sugar labeled nucleotides at various positions were used for structure determination of PTB in complex with its target RNA sequence. We had to use these very short tetramers and pentamers, because PTB RBD1, RBD2 and RBD4 recognize only 3 nt and RBD3 only 5 nt (16) . As illustrated in the 13 C HSQC spectrum of S3 bound to PTB RBD34 H134A, complete or partial 13 C-labeling of the sugar moieties of these short RNAs allows resolving the strong proton resonance overlap in the sugar region of the RNA in complex with PTB ( Figure 1A) . The RNAs containing only labeled uracils (S2 and S4) were essential to confirm the resonance assignments of the bound RNAs ( Figure 1B ) and to unambiguously derive intermolecular NOEs between the sugar moiety and the protein side chains. Isotope-labeling of the RNAs was essential to this structure determination as 50 and 67% of the intermolecular NOEs involved RNA sugar resonances in the complex with RBD3 and RBD4 of PTB, respectively (16) .
NMR study of the 13 C 5 -sugar labeled UGCAUGU in complex with Fox-1
The partially 13 C-labeled RNA oligonucleotides S5 and S6 were used to determine the structure with Fox-1 (16) . The two RNAs were essential to unambiguously assign the RNA resonances and to collect a high number of intra-and intermolecular NOE-derived constraints for UGCAUGU in complex with Fox-1. Without isotopically labeled RNA, the resonance assignment of the 7 nt RNA in complex was difficult and not unambiguous. While the proton resonances within each individual nucleoside could be linked using 2D NOESY and 2D TOCSY spectra, it was not possible to unambiguously place each individually assigned nucleotide spin-systems in the RNA sequence. In particular, we were doubtful about which spin-systems were corresponding to U5 and U7. With the 2D 13 C HSQC spectra of the partially 13 C-labeled RNA S6 and S7 in complex with Fox-1, these ambiguities could be solved, as S6 contains a 13 C 5 -labeled U5 and S7 a 13 C 5 -labeled U7 (Figure 2A ). Importantly, with the particular labeling scheme present in S6 and S7, in which 13 C 5 -labeled and unlabeled nucleotides are present in alternation, unusual internucleotide sugar-sugar NOEs could be assigned using X-filter NOESY spectra (20) ( Figure 2B ). In total, 39 internucleotide sugar-sugar NOEs were assigned, which corresponds to 68% of the internucleotide constraints and one-third (31%) of the intra-RNA constraints. Only five of these internucleotide sugar-sugar NOEs could be assigned using an unlabeled RNA, the remaining 34 could only be resolved using labeled S6 and S7 due to ambiguity or resonance overlap. Similarly, of the 149 intermolecular distance constraints, which were used to calculate the Fox-1 complex structure, 83 originate from the sugar protons of the RNA and 57 of these could not have been assigned without the help of the labeled oligonucleotides (15) . A structure calculation without the distance constraints from the 13 C-labels resulted in a set of structures in which the RNA is significantly less defined: the RMSD of the heavy atoms of the RNA is 1.02 s as compared to 0.55 s in the case when all NOE distance constraints were included ( Figure 2C ). While each nucleotide is affected, the effect is strongest at the 5 0 and 3 0 terminal ends of the RNA. In particular, nucleotide U7 does not converge to one particular conformation ( Figure 2C ). Furthermore, the relative orientation of protein and RNA is less precise ( Figure 2C ). The complex structure of Fox-1 using all constraints is extraordinarily well defined, allowing a detailed analysis of the individual hydrogen bond, van der Waals and electrostatic interactions at the protein-RNA interface (15) . In the structures obtained with the reduced set of constraints, an equal level of precision cannot be reached. Especially the intermolecular contacts to the RNA backbone are more heterogeneous. For example, a salt bridge between lysine 156 and the phosphate between G6 and U7 is observed in 28 of 30 structures ( Figure 2C, left) . In contrast, this salt bridge is observed in only 11 of the 30 structures obtained with the smaller number of NOE distance constraints ( Figure 2C, middle) . Hence, these NOEs were critical to determine with high precision the very unusual structure that the RNA adopts when bound to the RBD of Fox-1.
CONCLUSION AND PERSPECTIVES
In conclusion, we present a short and efficient synthetic access to 2 0 -O-TOM protected ribonucleoside phosphoramidites containing 13 C-labeled sugar moieties. The site-specific NOESY spectrum of 1 mM Fox-1 (uniformly 13 C-labeled) in complex with UGCAUGU (unlabeled). In this spectrum, NOE cross-peaks arise only from intra-RNA correlations; overlap is reduced but assignments remain ambiguous. Middle right: the same section of a w1-filtered, w2-edited 2D NOESY spectrum of 1 mM Fox-1 (unlabeled) in complex with S6. NOE cross-peaks arise from correlations of protons attached to 13 C (w2) with protons attached to 12 C (w1). Right: the same section of a w1-filtered, w2-edited 2D NOESY spectrum of 1 mM Fox-1 (unlabeled) in complex with S7. NOE cross-peaks arise from correlations of protons attached to 13 C (w2) with protons attached to 12 C (w1). Underlined NOE assignments are displayed in the structure of the complex with green dashed lines in (C). Overlap and ambiguity are significantly reduced in the spectra with S6 and S7 and many internucleotide cross-peaks can be assigned due to the alternating labeling scheme. (C) Left: overlay of the 30 final structures of Fox-1 in complex with UGCAUGU calculated using the entire set of NOE distance constraints [PDB code: 2ERR] (15) . Middle: overlay of the 30 final structures of Fox-1 in complex with UGCAUGU calculated using only those NOE distance constraints that could be assigned with unlabeled RNA oligonucleotides. The structures are superimposed on the heavy atoms of the RNA; the protein backbone is shown in black, the heavy atoms of the RNA are in red, and the side chains of F126 and K156 are in green and blue, respectively. Right: sections of one representative structure of the Fox-1-UGACUGU complex calculated using the entire set of NOEs. The protein backbone is depicted in ribbon representation (gray), aromatic protein side chains are shown in black, and the RNA is shown in red. Protons are displayed in gray.
introduction of these 13 C-labeled nucleotides into RNA sequences permitted a straightforward and unambiguous resonance assignment of their complexes with PTB and Fox-1. The analysis of sets of RNA sequences with alternating labeling patterns allowed the assignments of numerous unusual sugar-sugar and intermolecular NOEs, which substantially improved the precision and accuracy of the resulting structures. Use of chemically synthesized 13 C-labeled RNA sequences is likely to facilitate the study of singlestranded RNA binding proteins in complex with their target RNAs (21) , particularly RNA binding proteins targeting low complexity or repeat sequences that are numerous in posttranscriptional gene regulation (22) (23) (24) .
